Biggest News Aggregation in the World
📰 Granted News

Page 88 - Granted News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Granted. Real-time updates on events, politics, business and more.

Takeda's Biologics License Application (BLA) for Dengue Vaccine Candidate (TAK-003) Granted Priority Review by U.S. Food and Drug Administration

OSAKA, Japan and CAMBRIDGE, Massachusetts - Takeda announced that the U.S. Food and Drug Administration has accepted and granted priority review of the Biologics License Application for TAK-003,... | November 23, 2022
American Samoa United States Sri Lanka Puerto Rico Dominican Republic United Kingdom

EQS-News: Foresight Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirements

EQS-News: Foresight Autonomous Holdings Ltd. Foresight Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirements 22.11.2022 / 17:10 CET/CEST The issuer is solely responsible for the content of this announcement. Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FR...
United States Miri Segal Scharia Company Adss Foresight Automotive Ltd Foresight Changzhou Automotive Ltd Foresight Autonomous Holdings Ltd

EQS-News: Foresight Autonomous Holdings Ltd.: Foresight Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirements

EQS-News: Foresight Autonomous Holdings Ltd. Foresight Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirements 22.11.2022 / 17:10 CET/CEST The issuer
United States Miri Segal Scharia Company Adss Foresight Automotive Ltd Foresight Changzhou Automotive Ltd Foresight Autonomous Holdings Ltd

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Akari Therapeutics Plc: Akari Therapeutics Granted FDA Rare Pediatric Disease Designation of Nomacopan for the Treatment of Pediatric HSCT-TMA

NEW YORK and LONDON, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases
City Of United Kingdom Mike Moyer Eliza Schleifstein Rachelle Jacques Exchange Commission

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science